| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody-Based Treatment Approaches in Multiple Myeloma
|
Hosoya, Hitomi
|
|
|
16 |
2 |
p. 183-191
|
artikel
|
| 2 |
Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job
|
Schwerdtfeger, Melanie
|
|
|
16 |
2 |
p. 218-233
|
artikel
|
| 3 |
Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
|
Marneni, Naimisha
|
|
|
16 |
2 |
p. 148-161
|
artikel
|
| 4 |
Enteropathy-Associated T cell Lymphoma
|
Al Somali, Zakiah
|
|
|
16 |
2 |
p. 140-147
|
artikel
|
| 5 |
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery
|
Miller, Tamara P.
|
|
|
16 |
2 |
p. 126-131
|
artikel
|
| 6 |
Goal of a “Good Death” in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close?
|
Kuczmarski, Thomas M.
|
|
|
16 |
2 |
p. 117-125
|
artikel
|
| 7 |
IDH Inhibitors in AML—Promise and Pitfalls
|
McMurry, Hannah
|
|
|
16 |
2 |
p. 207-217
|
artikel
|
| 8 |
MRD Assessment in Multiple Myeloma: Progress and Challenges
|
Bertamini, Luca
|
|
|
16 |
2 |
p. 162-171
|
artikel
|
| 9 |
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches
|
Grieselhuber, Nicole R.
|
|
|
16 |
2 |
p. 192-206
|
artikel
|
| 10 |
Progress in the Management of Smoldering Multiple Myeloma
|
Schmidt, Timothy M.
|
|
|
16 |
2 |
p. 172-182
|
artikel
|
| 11 |
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond
|
Banerjee, Rahul
|
|
|
16 |
2 |
p. 132-139
|
artikel
|
Tijdschrift beschrijving